CMKLR1 and metabolic dysfunction-associated steatotic liver disease: Studies have shown that berberine can effectively treat NAFLD by reducing the expression of chemokine-like receptor 1 (CMKLR1) and CC-chemokine receptor-2 (CCR2) mRNA.